BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38220413)

  • 1. Can curcumin supplementation break the vicious cycle of inflammation, oxidative stress, and uremia in patients undergoing peritoneal dialysis?
    Reis DCMV; Alvarenga L; Cardozo LFMF; Baptista BG; Fanton S; Paiva BR; Ribeiro-Alves M; Fortunato RS; Vasconcelos AL; Nakao LS; Sanz CL; Berretta AA; Leite M; Mafra D
    Clin Nutr ESPEN; 2024 Feb; 59():96-106. PubMed ID: 38220413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Brazilian Green Propolis extract on inflammation in patients with chronic kidney disease on peritoneal dialysis: A randomised double-blind controlled clinical trial.
    Baptista BG; Fanton S; Ribeiro M; Cardozo LF; Regis B; Alvarenga L; Ribeiro-Alves M; Berretta AA; Shiels PG; Mafra D
    Phytomedicine; 2023 Jun; 114():154731. PubMed ID: 36934668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study.
    Alvarenga L; Salarolli R; Cardozo LFMF; Santos RS; de Brito JS; Kemp JA; Reis D; de Paiva BR; Stenvinkel P; Lindholm B; Fouque D; Mafra D
    Clin Nutr; 2020 Dec; 39(12):3594-3600. PubMed ID: 32204978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression.
    Stockler-Pinto MB; Soulage CO; Borges NA; Cardozo LFMF; Dolenga CJ; Nakao LS; Pecoits-Filho R; Fouque D; Mafra D
    Int Urol Nephrol; 2018 Feb; 50(2):347-354. PubMed ID: 29151180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin supplementation improves oxidative stress and inflammation biomarkers in patients undergoing hemodialysis: a secondary analysis of a randomized controlled trial.
    Alvarenga L; Cardozo LFMF; Da Cruz BO; Paiva BR; Fouque D; Mafra D
    Int Urol Nephrol; 2022 Oct; 54(10):2645-2652. PubMed ID: 35347555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2.
    Pedruzzi LM; Cardozo LF; Daleprane JB; Stockler-Pinto MB; Monteiro EB; Leite M; Vaziri ND; Mafra D
    J Nephrol; 2015 Aug; 28(4):495-501. PubMed ID: 25585822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.
    Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D
    Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane Supplementation Did Not Modulate NRF2 and NF-kB mRNA Expressions in Hemodialysis Patients.
    Ribeiro M; Cardozo LF; Paiva BR; Baptista BG; Fanton S; Alvarenga L; Lima LS; Britto I; Nakao LS; Fouque D; Ribeiro-Alves M; Mafra D
    J Ren Nutr; 2024 Jan; 34(1):68-75. PubMed ID: 37619675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistant starch type-2 enriched cookies modulate uremic toxins and inflammation in hemodialysis patients: a randomized, double-blind, crossover and placebo-controlled trial.
    Esgalhado M; Kemp JA; Paiva BR; Brito JS; Cardozo LFMF; Azevedo R; Cunha DB; Nakao LS; Mafra D
    Food Funct; 2020 Mar; 11(3):2617-2625. PubMed ID: 32159187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Dietary Supplementation With Curcumin on Redox Status and Nrf2 Activation in Patients With Nondiabetic or Diabetic Proteinuric Chronic Kidney Disease: A Pilot Study.
    Jiménez-Osorio AS; García-Niño WR; González-Reyes S; Álvarez-Mejía AE; Guerra-León S; Salazar-Segovia J; Falcón I; Montes de Oca-Solano H; Madero M; Pedraza-Chaverri J
    J Ren Nutr; 2016 Jul; 26(4):237-44. PubMed ID: 26915483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Bach1 mRNA expression in patients with chronic kidney disease: A preliminary study.
    Mafra D; Alvarenga L; Ribeiro M; Baptista BG; Fanton S; Paiva BR; Trugilho L; Kemp JA; Alves-Ribeiro M; Cardozo LFMF
    Hemodial Int; 2023 Jul; 27(3):301-307. PubMed ID: 37010133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Resveratrol Supplementation in Nrf2 and NF-κB Expressions in Nondialyzed Chronic Kidney Disease Patients: A Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Trial.
    Saldanha JF; Leal VO; Rizzetto F; Grimmer GH; Ribeiro-Alves M; Daleprane JB; Carraro-Eduardo JC; Mafra D
    J Ren Nutr; 2016 Nov; 26(6):401-406. PubMed ID: 27523436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper.
    Headley SA; Chapman DJ; Germain MJ; Evans EE; Hutchinson J; Madsen KL; Ikizler TA; Miele EM; Kirton K; O'Neill E; Cornelius A; Martin B; Nindl B; Vaziri ND
    BMC Nephrol; 2020 Nov; 21(1):517. PubMed ID: 33243160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant starch supplementation effects on plasma indole 3-acetic acid and aryl hydrocarbon receptor mRNA expression in hemodialysis patients: Randomized, double blind and controlled clinical trial.
    Azevedo R; Esgalhado M; Kemp JA; Regis B; Cardozo LF; Nakao LS; Brito JS; Mafra D
    J Bras Nefrol; 2020; 42(3):273-279. PubMed ID: 32459282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cranberry supplementation on toxins produced by the gut microbiota in chronic kidney disease patients: A pilot randomized placebo-controlled trial.
    Teixeira KTR; Moreira LSG; Borges NA; Brum I; de Paiva BR; Alvarenga L; Nakao LS; Leal VO; Carraro-Eduardo JC; Rodrigues SD; Lima JD; Ribeiro-Alves M; Mafra D
    Clin Nutr ESPEN; 2022 Feb; 47():63-69. PubMed ID: 35063244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis.
    Panahi Y; Hosseini MS; Khalili N; Naimi E; Majeed M; Sahebkar A
    Clin Nutr; 2015 Dec; 34(6):1101-8. PubMed ID: 25618800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial.
    Helli B; Gerami H; Kavianpour M; Heybar H; Hosseini SK; Haghighian HK
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2090-2098. PubMed ID: 33397249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Resveratrol Supplementation Reduce Uremic Toxin Plasma Levels From the Gut Microbiota in Nondialyzed Patients With Chronic Kidney Disease?
    Alvarenga L; Cardozo LFMF; Leal VO; Kemp JA; Saldanha JF; Ribeiro-Alves M; Meireles T; Nakao LS; Mafra D
    J Ren Nutr; 2022 Nov; 32(6):685-691. PubMed ID: 35122992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway.
    Soetikno V; Sari FR; Lakshmanan AP; Arumugam S; Harima M; Suzuki K; Kawachi H; Watanabe K
    Mol Nutr Food Res; 2013 Sep; 57(9):1649-59. PubMed ID: 23174956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial.
    Panahi Y; Ghanei M; Bashiri S; Hajihashemi A; Sahebkar A
    Drug Res (Stuttg); 2015 Nov; 65(11):567-73. PubMed ID: 25268878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.